RGNX
Olivier Danos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Olivier Danos
The proxy statement of REGENXBIO Inc. reports total compensation of $2,956,949 for Olivier Danos in fiscal 2024, including a base salary of $522,348. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
REGENXBIO Inc. (RGNX)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- Kenneth T. Mills Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $522,348 | $2,956,949 |
| 2023 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $502,257 | $2,985,416 |
| 2022 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $482,940 | $2,147,828 |
| 2021 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $455,604 | $2,797,694 |
| 2020 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $433,908 | $1,805,415 |
| 2019 | REGENXBIO Inc. (RGNX) | EVP, Chief Scientific Officer | $421,270 | $1,926,420 |
| 2018 | REGENXBIO Inc. (RGNX) | Senior Vice President, Chief Scientific Officer | $409,000 | $1,613,769 |
Recent activity
No call appearances or filed executive changes recorded yet.